{rfName}
TM

Indexed in

APC

4 060,00 Dollars
doaj

Altmetrics

Impact on the Sustainable Development Goals (SDGs)

Share

November 3, 2021
Publications
>
Meeting Abstract
No

TMPRSS2-ERG expression and clinical evolution of metastatic hormone sensitive prostate cancer

Publicated to: Annals Of Oncology. 32 S661-S662 - 2021-09-21 32(), DOI: 10.1016/j.annonc.2021.08.1138

Authors: Aversa, C; Jimenez, N; Marín-Aguilera, M; Ferrer, L; Rodríguez-Carunchio, L; Diaz-Mercedes, S; Pous, AF; Rodriguez-Vida, A; Santasusana, MD; Gorina, MF; Duran, MAC; Costa, SC; Chirivella, I; Rivera, DH; Gonzalez-Billalabeitia, E; Jiménez-Peralta, D; Galceran, JC; Rodriguez, CS; Torras, OR; Mellado, B

Affiliations

Fdn Inst Valenciano Oncol, Dept Med Oncol, Valencia, Spain - Author
Hosp Badalona Germans Trias & Pujol, Dept Med Oncol, Inst Catala Oncol Badalona, Med Oncol Dept, Badalona, Spain - Author
Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain - Author
Hosp Clin Barcelona, Dept Pathol, Barcelona, Spain - Author
Hosp Clin Univ Valencia, Dept Med Oncol, Valencia, Spain - Author
Hosp Gen Granollers, Dept Med Oncol, Granollers, Spain - Author
Hosp Mar, Dept Med Oncol, Barcelona, Spain - Author
Hosp Univ Morales Meseguer, Dept Med Oncol, Murcia, Spain - Author
Hosp Univ Morales Meseguer, Dept Urol, Murcia, Spain - Author
Hosp Virgen Rocio, Dept Med Oncol, Seville, Spain - Author
Inst Invest Biomed August Pi & Sunyer IDIBAPS, Traslat Genom & Targeted Therapeut Solid Tumors L, Barcelona, Spain - Author
Vall Hebron Univ Hosp, Dept Med Oncol, Barcelona, Spain - Author
Xarxa Assistencial Univ Manresa, Hosp Sant Joan Deu Althaia, Dept Med Oncol, Manresa 7, Spain - Author
See more

Keywords

Good health and well-being

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Annals Of Oncology due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2021, it was in position 5/245, thus managing to position itself as a Q1 (Primer Cuartil), in the category Oncology. Notably, the journal is positioned above the 90th percentile.

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-12-16:

  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 6 (PlumX).
Continuing with the social impact of the work, it is important to emphasize that, due to its content, it can be assigned to the area of interest of ODS 3 - Good Health And Well-being, with a probability of 84% according to the mBERT algorithm developed by Aurora University.

Leadership analysis of institutional authors

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (Aversa, Caterina) and Last Author (Mellado González, Begoña).

Awards linked to the item

Funded by a grant from Janssen Pharmaceuticals, number 212082PCR4056. ISCIII and ERDF (PI18/174). CERCA Programme/Generalitat de Catalunya.